BridgeMD
Tests treatment safety and results for Acceptability Study
Official title Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
ClinicalTrials.gov ID: NCT06751433
What this study is testing
- What it's testing
- Evaluation of the safety and topical efficacy of a scar gel after 90 days of continuous use, comparing it to a benchmark for preventing hypertrophic scars and improving appearance, hydration and pigmentation.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Participants of both sexes aged between 18 and 70 years;
- Participants with recent scars (\<30 days);
- Participants with phototypes III to VI according to the Fitzpatrick scale;
- Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;
- Understand, agree to and sign the free and informed consent form.
You likely can't join if
- Pregnancy or risk of pregnancy;
- History of atopic or allergic reactions to cosmetic products;
- Participants who are using topical antibiotics or other skin products on the same area being evaluated;
- Immunosuppression due to drugs or active diseases;
- Decompensated endocrine diseases;
- Relevant clinical history or current evidence of alcohol or other drug abuse;
See the full eligibility criteria
- Participants of both sexes aged between 18 and 70 years;
- Participants with recent scars (\<30 days);
- Participants with phototypes III to VI according to the Fitzpatrick scale;
- Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;
- Understand, agree to and sign the free and informed consent form.
- Types of scars: cesarean section, breast implant or blunt cut injury.
- Pregnancy or risk of pregnancy;
- History of atopic or allergic reactions to cosmetic products;
- Participants who are using topical antibiotics or other skin products on the same area being evaluated;
- Immunosuppression due to drugs or active diseases;
- Decompensated endocrine diseases;
- Relevant clinical history or current evidence of alcohol or other drug abuse;
- Known history or suspected intolerance to products in the same category;
- Intense sun exposure up to 15 days before the evaluation;
- Patients who are using topical antibiotics or other skin products on the same area being evaluated.
The study team makes the final eligibility decision.
Where it's taking place
- Osasco, São Paulo, Brazil
- Osasco, Brazil
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Osasco, São Paulo, Brazil; Osasco, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.